MIGUEL ALBINO, MD
Medical Oncology Physician · AUSTIN, TX
Individual Active NPI 1205060746
Medicare payment data Part B · 2024
| Year | Beneficiaries | Services | Submitted | Allowed | Paid |
|---|---|---|---|---|---|
| 2024 | 430 | 181,220.1 | $14,395,319 | $3,912,933 | $3,115,793 |
| 2023 | 388 | 142,677 | $10,540,654 | $2,686,800 | $2,138,843 |
| 2022 | 445 | 150,073 | $9,136,909 | $2,281,680 | $1,821,303 |
Top procedures (2024)
| HCPCS | Description | Services | Avg allowed | Avg paid |
|---|---|---|---|---|
| J1453 | Injection, fosaprepitant, 1 mg | 27,150 | $0 | $0 |
| J9267 | Injection, paclitaxel, 1 mg | 20,698 | $0 | $0 |
| J1756 | Injection, iron sucrose, 1 mg | 15,700 | $0 | $0 |
| J9271 | Injection, pembrolizumab, 1 mg | 14,700 | $54 | $43 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 3,864 | $0 | $0 |
| Q5129 | Injection, bevacizumab-adcd (vegzelma), biosimilar, 10 mg | 2,930 | $63 | $50 |
| J2469 | Injection, palonosetron hcl, 25 mcg | 2,280 | $1 | $1 |
| J1626 | Injection, granisetron hydrochloride, 100 mcg | 1,440 | $0 | $0 |
| 96375 | Injection of additional new drug or substance into vein | 915 | $16 | $12 |
| J9045 | Injection, carboplatin, 50 mg | 886 | $4 | $3 |
| Q5106 | Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units | 750 | $7 | $6 |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | 520 | $131 | $104 |
Taxonomy & licensure
| Specialty | Code | Primary | License | State |
|---|---|---|---|---|
| Medical Oncology Physician | 207RX0202X | ✓ | Q7825 | TX |
| Internal Medicine Physician | 207R00000X | 18296 | PR |
Medicare eligibility
- Part B
- Yes
- DME
- Yes
- Home health
- Yes
- Power mobility
- Yes
- Hospice
- Yes
Other Medical Oncology Physician providers in Texas
- NPI 1447414776
- NPI 1437400702
- NPI 1205079373
- NPI 1700909744
- NPI 1487818811
- NPI 1073000766
- NPI 1174686364
- NPI 1982642914
Source: NPPES (public domain) and CMS Medicare Physician & Other Practitioners data. Not affiliated with CMS, NPPES, or any government agency.